美股A股
StockGist
Back
8-K2026-03-12· grok-4-1-fast-non-reasoning

NKTR · Nektar Therapeutics

0001213900-26-027026

SEC filing

Summary

Nektar Therapeutics issued a press release on March 12, 2026, reporting fourth quarter and full year results of operations and financial condition. The press release is filed as Exhibit 99.1.

Key takeaways